trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Liu L and Clipstone NA Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. 2007 J. Cell. Biochem. pmid:16888802
Kim TY et al. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. 2006 Cancer Res. pmid:16885346
Suzuki T et al. Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. 2006 J. Med. Chem. pmid:16884291
Gaymes TJ et al. Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis? 2006 Mol. Cancer Res. pmid:16877702
van den Boom J et al. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. 2006 Int. J. Cancer pmid:16865689
Villanueva R et al. Histone deacetylase 3 represses HTLV-1 tax transcription. 2006 Oncol. Rep. pmid:16865259
Zhang X et al. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. 2006 Oncol. Rep. pmid:16865256
Wagner S et al. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. 2006 J. Biol. Chem. pmid:16861234
Karvonen U et al. Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. 2006 Exp. Cell Res. pmid:16860317
Olaharski AJ et al. The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro. 2006 Toxicol. Sci. pmid:16857700
Bell CW et al. The extracellular release of HMGB1 during apoptotic cell death. 2006 Am. J. Physiol., Cell Physiol. pmid:16855214
Dannenberg LO and Edenberg HJ Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. 2006 BMC Genomics pmid:16854234
Puppin C et al. HEX expression and localization in normal mammary gland and breast carcinoma. 2006 BMC Cancer pmid:16854221
Das PM et al. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. 2006 Mol. Cancer pmid:16848908
Monte M et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16847267
Kimura N et al. Alteration of developmental program in Paramecium by treatment with trichostatin a: a possible involvement of histone modification. 2006 Protist pmid:16839811
Leng Y and Chuang DM Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. 2006 J. Neurosci. pmid:16837598
Sato K et al. Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment. 2006 Int. J. Oncol. pmid:16820886
Mori T et al. Estrogen receptor-alpha methylation predicts melanoma progression. 2006 Cancer Res. pmid:16818643
Foltz G et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. 2006 Cancer Res. pmid:16818640
Lau QC et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. 2006 Cancer Res. pmid:16818622
Son YO et al. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata. 2006 J. Cell. Biochem. pmid:16817225
Aung HT et al. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. 2006 FASEB J. pmid:16816106
Zampetaki A et al. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. 2006 Biochem. Biophys. Res. Commun. pmid:16814255
Wang Y et al. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. 2006 Arthritis Rheum. pmid:16802366
Pampalakis G and Sotiropoulou G Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. 2006 Biol. Chem. pmid:16800739
Wallace DM et al. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina. 2006 Invest. Ophthalmol. Vis. Sci. pmid:16799012
Suuronen T et al. Characterization of the pro-inflammatory signaling induced by protein acetylation in microglia. 2006 Neurochem. Int. pmid:16797784
Iacomino G et al. Effects of histone deacetylase inhibitors on p55CDC/Cdc20 expression in HT29 cell line. 2006 J. Cell. Biochem. pmid:16795040
Wu Y and Guo SW Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780. 2006 Gynecol. Obstet. Invest. pmid:16778450
Sharma D et al. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. 2006 Cancer Res. pmid:16778215
Zhao YM et al. Effects of histone deacetylase inhibitors on transcriptional regulation of the hsp70 gene in Drosophila. 2006 Cell Res. pmid:16775628
Kwon O et al. NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. 2006 Carcinogenesis pmid:16774937
Tsuji H et al. Dynamic and reversible changes in histone H3-Lys4 methylation and H3 acetylation occurring at submergence-inducible genes in rice. 2006 Plant Cell Physiol. pmid:16774928
Zhou C et al. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. 2006 Int. J. Oncol. pmid:16773209
Li GC et al. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. 2006 Int. J. Urol. pmid:16771729
Vanniasinkam T et al. Trichostatin-A enhances adaptive immune responses to DNA vaccination. 2006 J. Clin. Virol. pmid:16765083
Kwon HS et al. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. 2006 Mar-Apr Biochim. Biophys. Acta pmid:16757381
Morinobu A et al. Trichostatin A cooperates with Fas-mediated signal to induce apoptosis in rheumatoid arthritis synovial fibroblasts. 2006 J. Rheumatol. pmid:16755652
Rouhi A et al. Plasticity of Ly49g expression is due to epigenetics. 2007 Mol. Immunol. pmid:16750269
Qi H and Ratnam M Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. 2006 Cancer Res. pmid:16740727
Vulcano F et al. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. 2006 Exp. Cell Res. pmid:16739251
Cabrero JR et al. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity. 2006 Mol. Biol. Cell pmid:16738306
Dannenberg LO et al. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. 2006 Alcohol. Clin. Exp. Res. pmid:16737450
Kong Y et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. 2006 Circulation pmid:16735673
Santander VS et al. Tubulin must be acetylated in order to form a complex with membrane Na(+),K (+)-ATPase and to inhibit its enzyme activity. 2006 Mol. Cell. Biochem. pmid:16733802
Kim Y et al. Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. 2006 J. Steroid Biochem. Mol. Biol. pmid:16723222
Yamada N et al. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. 2006 Int. J. Cancer pmid:16721789
Nygård M et al. Thyroid hormone-mediated negative transcriptional regulation of Necdin expression. 2006 J. Mol. Endocrinol. pmid:16720720
Imre G et al. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation. 2006 Cancer Res. pmid:16707469
Ibanez de Caceres I et al. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. 2006 Cancer Res. pmid:16707423
Wischnewski F et al. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. 2006 Mol. Cancer Res. pmid:16687489
Armstrong K et al. NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells. 2006 Prostate pmid:16683270
Hernandez M et al. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. 2006 Prostate pmid:16652385
Akiyama T et al. Inadequate histone deacetylation during oocyte meiosis causes aneuploidy and embryo death in mice. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16651529
Jung EJ et al. Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. 2007 Cancer Lett. pmid:16647201
Uchida H et al. Human endometrial cytodifferentiation by histone deacetylase inhibitors. 2006 Hum. Cell pmid:16643606
Pavan Kumar P et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. 2006 Mol. Cell pmid:16630892
Magnaghi-Jaulin L and Jaulin C Histone deacetylase activity is necessary for chromosome condensation during meiotic maturation in Xenopus laevis. 2006 Chromosome Res. pmid:16628502
Januchowski R et al. Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells. 2007 Cancer Lett. pmid:16624484
Banwell CM et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. 2006 Clin. Cancer Res. pmid:16609009
Jaalouk DE et al. Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors. 2006 Virol. J. pmid:16603064
Wang Q et al. Histone deacetylation is required for orderly meiosis. 2006 Cell Cycle pmid:16582639
Stefanovsky V and Moss T Regulation of rRNA synthesis in human and mouse cells is not determined by changes in active gene count. 2006 Cell Cycle pmid:16582637
Nusinzon I and Horvath CM Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. 2006 Mol. Cell. Biol. pmid:16581785
Woo HJ et al. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. 2007 Exp. Mol. Pathol. pmid:16574101
Piacentini P et al. Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 2006 Virchows Arch. pmid:16568310
Lund P et al. Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. 2006 Oncogene pmid:16568090
Rebbaa A et al. The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. 2006 Cell Death Differ. pmid:16557274
Gagnon JF et al. Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. 2006 Clin. Cancer Res. pmid:16551870
Hsiao CH et al. Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. 2006 Exp. Hematol. pmid:16543060
Bishop CL et al. Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA. 2006 Mol. Cell. Biol. pmid:16537904
Tada Y et al. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. 2006 J. Natl. Cancer Inst. pmid:16537832
Gastaldi T et al. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. 2006 Carcinogenesis pmid:16537559
Vinken M et al. Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. 2006 Toxicol. Sci. pmid:16531468
Chuang HC et al. Histone deacetylase 3 binds to and regulates the GCMa transcription factor. 2006 Nucleic Acids Res. pmid:16528103
Bates EA et al. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. 2006 J. Neurosci. pmid:16525063
Endo T et al. Activities of maturation-promoting factor (MPF) and mitogen-activated protein kinase (MAPK) are not required for the global histone deacetylation observed after germinal vesicle breakdown (GVBD) in porcine oocytes. 2006 Reproduction pmid:16514187
Rokhlin OW et al. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. 2006 Mol. Cancer Res. pmid:16513842
Kong X et al. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. 2006 Mol. Cell. Biol. pmid:16507982
Hellebrekers DM et al. Angiostatic activity of DNA methyltransferase inhibitors. 2006 Mol. Cancer Ther. pmid:16505122
Ostapkowicz A et al. Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. 2006 Mol. Cancer Ther. pmid:16505096
Alao JP et al. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. 2006 Mol. Cancer pmid:16504004
Alao JP et al. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. 2006 Mol. Cancer pmid:16503970
Kim MY et al. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. 2006 Mol. Endocrinol. pmid:16497729
Song YF et al. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma. 2006 J. Clin. Pathol. pmid:16489177
Swanson S Invited commentary. 2006 Ann. Thorac. Surg. pmid:16488718
Mukhopadhyay NK et al. Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. 2006 Ann. Thorac. Surg. pmid:16488717
Weaver IC et al. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16484373
Banchio C et al. Role of histone deacetylase in the expression of CTP:phosphocholine cytidylyltransferase alpha. 2006 J. Biol. Chem. pmid:16484221
Rybouchkin A et al. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. 2006 Biol. Reprod. pmid:16481594
Pedram M et al. Telomere position effect and silencing of transgenes near telomeres in the mouse. 2006 Mol. Cell. Biol. pmid:16479005
Baraz L et al. Tumor suppressor p53 regulates heparanase gene expression. 2006 Oncogene pmid:16474844
Osborn NK et al. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. 2006 Clin. Gastroenterol. Hepatol. pmid:16469682
Kim IA et al. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53. 2006 Clin. Cancer Res. pmid:16467109
Sonnemann J et al. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. 2006 Int. J. Oncol. pmid:16465382
Araki H et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. 2006 Exp. Hematol. pmid:16459182
Gialitakis M et al. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. 2006 Nucleic Acids Res. pmid:16452299
Fandy TE and Srivastava RK Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. 2006 Cancer Chemother. Pharmacol. pmid:16435155
Nambiar MP et al. Transcriptional induction of cholinesterase expression and protection against chemical warfare nerve agents. 2005 Chem. Biol. Interact. pmid:16429504